The Cancer News
AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER
Health Equity
Stay updated with the latest insights and developments in cancer care.
A Latino Lens
By Editorial Team
### **Listening to the Community to Fuel Outreach and Engagement** **By Dr. Kelly Meza** Dr. Ramirez and her team at Mays Cancer Center are dedicated to tackling the unequal impact of cancer an...
A Latino Lens
By Editorial Team
### **Listening to the Community to Fuel Outreach and Engagement** **By Dr. Kelly Meza** Dr. Ramirez and her team at Mays Cancer Center are dedicated to tackling the unequal impact of cancer an...
A Latino Lens
By Editorial Team
### **Listening to the Community to Fuel Outreach and Engagement** **By Dr. Kelly Meza** Dr. Ramirez and her team at Mays Cancer Center are dedicated to tackling the unequal impact of cancer an...
A 12 Year Journey to Enhance Minority Enrollment in Clinical Trials
By Binaytara Team
Dr. Sharad Ghamande, MD, FACOG delivered an insightful presentation titled "Can We Increase Accrual of Minorities in Rural Areas of the Country? A 12-Year Journey," shedding light on the imperative ne...
A 12 Year Journey to Enhance Minority Enrollment in Clinical Trials
By Binaytara Team
Dr. Sharad Ghamande, MD, FACOG delivered an insightful presentation titled "Can We Increase Accrual of Minorities in Rural Areas of the Country? A 12-Year Journey," shedding light on the imperative ne...
A 12 Year Journey to Enhance Minority Enrollment in Clinical Trials
By Binaytara Team
Dr. Sharad Ghamande, MD, FACOG delivered an insightful presentation titled "Can We Increase Accrual of Minorities in Rural Areas of the Country? A 12-Year Journey," shedding light on the imperative ne...
Access to Medications: Cases Studies in Solutions
By Editorial Team
**By Dr. Richa Parikh** In this talk, Dr. Dan Milner discusses various strategies to improve access to oncology drugs to patients both in the US and globally, in an equitable manner to mitigate disp...
Access to Medications: Cases Studies in Solutions
By Editorial Team
**By Dr. Richa Parikh** In this talk, Dr. Dan Milner discusses various strategies to improve access to oncology drugs to patients both in the US and globally, in an equitable manner to mitigate disp...
Access to Medications: Cases Studies in Solutions
By Editorial Team
**By Dr. Richa Parikh** In this talk, Dr. Dan Milner discusses various strategies to improve access to oncology drugs to patients both in the US and globally, in an equitable manner to mitigate disp...
Best Practices in Supporting LGBTQ+ Communities
By Editorial Team
At The Summit on Cancer Health Disparities 2024, in the session titled “Best Practices in Serving LGBTQ+ Communities,” Nakita Venus (they/them) and Elle Brooks (she/they) from Seattle’s LGBTQ Center, ...
Best Practices in Supporting LGBTQ+ Communities
By Editorial Team
At The Summit on Cancer Health Disparities 2024, in the session titled “Best Practices in Serving LGBTQ+ Communities,” Nakita Venus (they/them) and Elle Brooks (she/they) from Seattle’s LGBTQ Center, ...
Best Practices in Supporting LGBTQ+ Communities
By Editorial Team
At The Summit on Cancer Health Disparities 2024, in the session titled “Best Practices in Serving LGBTQ+ Communities,” Nakita Venus (they/them) and Elle Brooks (she/they) from Seattle’s LGBTQ Center, ...
Artificial Intelligence to Facilitate Cancer Care
By Dr. Brenda Santellano
**By Dr. Brenda Santellano -** **Research Associate at Georgia Cancer Center** [Dr. Jospeph Finkelstein, MD, PhD, FAMIA, FACMI](https://medicine.utah.edu/faculty/joseph-finkelstein) explored the tra...
Artificial Intelligence to Facilitate Cancer Care
By Dr. Brenda Santellano
**By Dr. Brenda Santellano -** **Research Associate at Georgia Cancer Center** [Dr. Jospeph Finkelstein, MD, PhD, FAMIA, FACMI](https://medicine.utah.edu/faculty/joseph-finkelstein) explored the tra...
Artificial Intelligence to Facilitate Cancer Care
By Dr. Brenda Santellano
**By Dr. Brenda Santellano -** **Research Associate at Georgia Cancer Center** [Dr. Jospeph Finkelstein, MD, PhD, FAMIA, FACMI](https://medicine.utah.edu/faculty/joseph-finkelstein) explored the tra...
Antibody Drug Conjugates
By Editorial Team
_**Author**: **Dr. Arya Mariam** **Roy** from Roswell Park Comprehensive Cancer Center_ **What are antibody drug conjugates (ADCs)?** Antibody drug conjugates (ADCs) are newer targeted medicines...
Antibody Drug Conjugates
By Editorial Team
_**Author**: **Dr. Arya Mariam** **Roy** from Roswell Park Comprehensive Cancer Center_ **What are antibody drug conjugates (ADCs)?** Antibody drug conjugates (ADCs) are newer targeted medicines...
Antibody Drug Conjugates
By Editorial Team
_**Author**: **Dr. Arya Mariam** **Roy** from Roswell Park Comprehensive Cancer Center_ **What are antibody drug conjugates (ADCs)?** Antibody drug conjugates (ADCs) are newer targeted medicines...
Authors' Take: Consequences of Cancer Diagnosis in India
By Editorial Team
This week, The Cancer News had the opportunity to connect with three authors (Dr. Aju Mathew, Sruti Ranganathan, and Dr. Edward Christopher Dee) of a recent article in the peer-reviewed Journal **Supp...
Authors' Take: Consequences of Cancer Diagnosis in India
By Editorial Team
This week, The Cancer News had the opportunity to connect with three authors (Dr. Aju Mathew, Sruti Ranganathan, and Dr. Edward Christopher Dee) of a recent article in the peer-reviewed Journal **Supp...
Authors' Take: Consequences of Cancer Diagnosis in India
By Editorial Team
This week, The Cancer News had the opportunity to connect with three authors (Dr. Aju Mathew, Sruti Ranganathan, and Dr. Edward Christopher Dee) of a recent article in the peer-reviewed Journal **Supp...
ASCO23 - WU-KONG6 Trial Summary
By Editorial Team
**Author:** Lei Deng, MD Roswell Park Comprehensive Cancer Center _**Live report from ASCO23, Chicago, IL**_ June 6, 2023 **[9002](https://meetings.asco.org/abstracts-presentations/220375) Sunvoze...
ASCO23 - WU-KONG6 Trial Summary
By Editorial Team
**Author:** Lei Deng, MD Roswell Park Comprehensive Cancer Center _**Live report from ASCO23, Chicago, IL**_ June 6, 2023 **[9002](https://meetings.asco.org/abstracts-presentations/220375) Sunvoze...
ASCO23 - WU-KONG6 Trial Summary
By Editorial Team
**Author:** Lei Deng, MD Roswell Park Comprehensive Cancer Center _**Live report from ASCO23, Chicago, IL**_ June 6, 2023 **[9002](https://meetings.asco.org/abstracts-presentations/220375) Sunvoze...
ASCO23 – LUNAR Study Summary
By Editorial Team
**Author:** Lei Deng, MD [Roswell Park Comprehensive Cancer Center](https://www.roswellpark.org/) _**Live report from ASCO23, Chicago, IL**_ June 6, 2023 [**LBA9005**](https://meetings.asco.org/ab...
ASCO23 – LUNAR Study Summary
By Editorial Team
**Author:** Lei Deng, MD [Roswell Park Comprehensive Cancer Center](https://www.roswellpark.org/) _**Live report from ASCO23, Chicago, IL**_ June 6, 2023 [**LBA9005**](https://meetings.asco.org/ab...
ASCO23 – LUNAR Study Summary
By Editorial Team
**Author:** Lei Deng, MD [Roswell Park Comprehensive Cancer Center](https://www.roswellpark.org/) _**Live report from ASCO23, Chicago, IL**_ June 6, 2023 [**LBA9005**](https://meetings.asco.org/ab...
A Summary of the DACOTA Trial
By Editorial Team
By Dr. Chepsy Philip [Believer's Church Medical College Hospital](https://www.bcmch.org/) Myeloproliferative - Chronic Myelomonocytic Leukemia (MP-CMML), a subset in the rare patient population of C...
A Summary of the DACOTA Trial
By Editorial Team
By Dr. Chepsy Philip [Believer's Church Medical College Hospital](https://www.bcmch.org/) Myeloproliferative - Chronic Myelomonocytic Leukemia (MP-CMML), a subset in the rare patient population of C...
A Summary of the DACOTA Trial
By Editorial Team
By Dr. Chepsy Philip [Believer's Church Medical College Hospital](https://www.bcmch.org/) Myeloproliferative - Chronic Myelomonocytic Leukemia (MP-CMML), a subset in the rare patient population of C...